Review of virological methods for laboratory diagnosis and characterization of monkeypox virus (MPXV): lessons learned from the 2022 Mpox outbreak
- PMID: 38179904
Review of virological methods for laboratory diagnosis and characterization of monkeypox virus (MPXV): lessons learned from the 2022 Mpox outbreak
Abstract
Monkeypox virus (MPXV), originally endemic in West Africa (Clade II) and Central Africa (Clade I), has recently emerged worldwide and has reinforced the need for rapid and accurate MPXV diagnostics. This review presents and critically discusses the range of virological methods for laboratory diagnosis and characterization of MPXV as well as related lessons learned and practical experience gained from the 2022 Mpox global outbreak. Real-time PCR is currently considered the diagnostic gold standard and ensures accurate and timely confirmation of suspected Mpox cases based on suspicious skin lesions, and digital PCR improves the precision of MPXV DNA quantification. Whole genome sequencing reveals the diversity within the Clade IIb outbreak and highlights the role of microevolution in the adaptation of the virus to the human host. Continuous genomic surveillance is important for better understanding of human-to-human transmission and prevention of the emergence of variola virus-like strains. Traditional virological methods such as electron microscopy and virus isolation remain essential for comprehensive virus characterization, particularly in the context of vaccine and antiviral drug development. Despite the current challenges, serological tests detecting a range of anti-MPXV antibodies are important adjunct diagnostic and research tools for confirmation of late-presenting or asymptomatic MPXV cases, contact tracing, epidemiological studies, seroepidemiological surveys, and better understanding of the role of IgG and neutralizing antibodies in the immune response to infection and vaccination. A multidisciplinary approach combining advanced molecular techniques with traditional virological methods is important for rapid and reliable diagnosis, surveillance, and control of the outbreak.
Similar articles
-
Differences in pathogenicity among the mpox virus clades: impact on drug discovery and vaccine development.Trends Pharmacol Sci. 2023 Oct;44(10):719-739. doi: 10.1016/j.tips.2023.08.003. Epub 2023 Sep 4. Trends Pharmacol Sci. 2023. PMID: 37673695 Review.
-
Alternative sampling specimens for the molecular detection of mpox (formerly monkeypox) virus.J Clin Virol. 2023 Feb;159:105372. doi: 10.1016/j.jcv.2022.105372. Epub 2022 Dec 26. J Clin Virol. 2023. PMID: 36608620 Free PMC article.
-
Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus.Nat Med. 2022 Aug;28(8):1569-1572. doi: 10.1038/s41591-022-01907-y. Epub 2022 Jun 24. Nat Med. 2022. PMID: 35750157 Free PMC article.
-
Human monkeypox virus: Epidemiologic review and research progress in diagnosis and treatment.J Clin Virol. 2024 Apr;171:105662. doi: 10.1016/j.jcv.2024.105662. Epub 2024 Feb 28. J Clin Virol. 2024. PMID: 38432097 Review.
-
Concurrent Clade I and Clade II Monkeypox Virus Circulation, Cameroon, 1979-2022.Emerg Infect Dis. 2024 Mar;30(3):432-443. doi: 10.3201/eid3003.230861. Epub 2024 Feb 7. Emerg Infect Dis. 2024. PMID: 38325363 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources